MNOV — MEDICINOVA INC catalysts
Next verified catalyst
2026-12-31 — MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceri · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-31 in 3mo
ESTIMATED |
READOUT
MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hyper
Phase 2 · Diabetes Mellitus, Type 2, Hypertriglyceridemia |
MNOV MEDICINOVA INC | MN-001, MN-001 placebo |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|